Corticosteroids in Patients With COVID-19 : What About the Control Group?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:72 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 72(2021), 6 vom: 15. März, Seite 1102-1103 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chroboczek, Tomasz [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 18.03.2021 Date Revised 31.05.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciaa768 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311274056 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311274056 | ||
| 003 | DE-627 | ||
| 005 | 20231225141912.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciaa768 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311274056 | ||
| 035 | |a (NLM)32548616 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chroboczek, Tomasz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corticosteroids in Patients With COVID-19 |b What About the Control Group? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.03.2021 | ||
| 500 | |a Date Revised 31.05.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 700 | 1 | |a Lacoste, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Wackenheim, Chloe |e verfasserin |4 aut | |
| 700 | 1 | |a Challan-Belval, Thibaut |e verfasserin |4 aut | |
| 700 | 1 | |a Amar, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Boisson, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Hubac, Jason |e verfasserin |4 aut | |
| 700 | 1 | |a Leduc, Dominique |e verfasserin |4 aut | |
| 700 | 1 | |a Masse, Colleen |e verfasserin |4 aut | |
| 700 | 1 | |a Dechaene, Victor |e verfasserin |4 aut | |
| 700 | 1 | |a Touihri-Maximin, Laetitia |e verfasserin |4 aut | |
| 700 | 1 | |a Megessier, Sandrine |e verfasserin |4 aut | |
| 700 | 1 | |a Lassale, Camille |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 72(2021), 6 vom: 15. März, Seite 1102-1103 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:72 |g year:2021 |g number:6 |g day:15 |g month:03 |g pages:1102-1103 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa768 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 72 |j 2021 |e 6 |b 15 |c 03 |h 1102-1103 | ||